Dr. Mandy Cohen, Director of the Centers for Disease Control and Prevention, is advocating comprehensive vaccination against respiratory infection during the fall.  This year, COVID and influenza vaccines can be administered concurrently during one visit with a possibility of the newly approved Respiratory Syncytial Virus (RSV) administered approximately two weeks later.  Splitting the times of administration among the three vaccines is recommended by Dr. William Schaffner, Professor of Preventive Medicine at Vanderbilt University Medical Center.  This is based on preliminary investigations showing that influenza and RSV vaccines could be mutually antagonistic with regard to immuno-simulatory efficiency. In subsequent years, it may be possible to combine all three vaccinations at a single time during the fall of 2023.  The RSV vaccine is recommended for adults 60 and over who are susceptible to respiratory infections.

Monoclonal antibody has been approved for infants to treat RSV. This treatment modality will be required if there is a surge in infections as in 2022, that resulted in a high number of pediatric hospital admissions.

Those coming into contact with live poultry should be immunized against influenza to avoid an unlikely but potentially serious recombinant event.